Multiple injections of bevacizumab improve best-corrected visual acuity (BCVA) and central macular thickness in patients with persistant clinically significant macular oedema (CSME)
Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.